Maryam Fouladi
Department of Oncology
St Jude Children's Research Hospital
332 North Lauderdale
Memphis
USA
Name/email consistency: high
- Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma. Fouladi, M., Chintagumpala, M., Ashley, D., Kellie, S., Gururangan, S., Hassall, T., Gronewold, L., Stewart, C.F., Wallace, D., Broniscer, A., Hale, G.A., Kasow, K.A., Merchant, T.E., Morris, B., Krasin, M., Kun, L.E., Boyett, J.M., Gajjar, A. J. Clin. Oncol. (2008)
- Phase I study of everolimus in pediatric patients with refractory solid tumors. Fouladi, M., Laningham, F., Wu, J., O'Shaughnessy, M.A., Molina, K., Broniscer, A., Spunt, S.L., Luckett, I., Stewart, C.F., Houghton, P.J., Gilbertson, R.J., Furman, W.L. J. Clin. Oncol. (2007)
- A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: a Children's Oncology Group study. Fouladi, M., Nicholson, H.S., Zhou, T., Laningham, F., Helton, K.J., Holmes, E., Cohen, K., Speights, R.A., Wright, J., Pollack, I.F. Cancer (2007)
- Histone deacetylase inhibitors in cancer therapy. Fouladi, M. Cancer Invest. (2006)
- Phase II study of oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid tumors: a pediatric brain tumor consortium study. Fouladi, M., Blaney, S.M., Poussaint, T.Y., Freeman, B.B., McLendon, R., Fuller, C., Adesina, A.M., Hancock, M.L., Danks, M.K., Stewart, C., Boyett, J.M., Gajjar, A. Cancer (2006)
- Intellectual and functional outcome of children 3 years old or younger who have CNS malignancies. Fouladi, M., Gilger, E., Kocak, M., Wallace, D., Buchanan, G., Reeves, C., Robbins, N., Merchant, T., Kun, L.E., Khan, R., Gajjar, A., Mulhern, R. J. Clin. Oncol. (2005)
- White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor. Fouladi, M., Chintagumpala, M., Laningham, F.H., Ashley, D., Kellie, S.J., Langston, J.W., McCluggage, C.W., Woo, S., Kocak, M., Krull, K., Kun, L.E., Mulhern, R.K., Gajjar, A. J. Clin. Oncol. (2004)
- Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high-grade glioma study CCG-945. Fouladi, M., Hunt, D.L., Pollack, I.F., Dueckers, G., Burger, P.C., Becker, L.E., Yates, A.J., Gilles, F.H., Davis, R.L., Boyett, J.M., Finlay, J.L. Cancer (2003)
- Clear cell ependymoma: a clinicopathologic and radiographic analysis of 10 patients. Fouladi, M., Helton, K., Dalton, J., Gilger, E., Gajjar, A., Merchant, T., Kun, L., Newsham, I., Burger, P., Fuller, C. Cancer (2003)
- Comparison of CSF cytology and spinal magnetic resonance imaging in the detection of leptomeningeal disease in pediatric medulloblastoma or primitive neuroectodermal tumor. Fouladi, M., Gajjar, A., Boyett, J.M., Walter, A.W., Thompson, S.J., Merchant, T.E., Jenkins, J.J., Langston, J.W., Liu, A., Kun, L.E., Heideman, R.L. J. Clin. Oncol. (1999)
